Vassiliki Papadimitrakopoulou, MD, on The Lung MAP Clinical Trial

Vassiliki Papadimitrakopoulou, MD, of MD Anderson Cancer Center, discusses the ways in which patients, investigators, and pharmaceutical companies are working together to accelerate research and access to care (Abstract MTE 02.01).

Related Videos

Lung Cancer

Lorraine Cheryl Pelosof, MD, PhD

Lorraine Cheryl Pelosof, MD, PhD, on Never-Smokers in NSCLC

Lorraine Cheryl Pelosof, MD, PhD, of UT Southwestern Medical Center, discusses her study findings, which demonstrate an increasing proportion of never-smokers among patients with n...

Lung Cancer

Barbara J. Gitlitz, MD

Barbara J. Gitlitz, MD: Genomics of Young Lung Cancer Study

Barbara J. Gitlitz, MD, of USC/Norris Cancer Center, discusses the first prospective study on the genomic drivers and demographics of lung cancer in patients under 40 who took part...

Lung Cancer

Fred R. Hirsch, MD, PhD and Paul A. Bunn, Jr., MD

Fred R. Hirsch, MD, PhD, and Paul A. Bunn, Jr., MD, on the Highlights of the World Conference on Lung Cancer

Fred R. Hirsch, MD, PhD, of the University of Colorado Health Science Center, and Paul A. Bunn, Jr, MD, of the University of Colorado Cancer Center, give their vie...

Lung Cancer

William D. Travis, MD

William D. Travis, MD, on Pathology and Genetics of Lung Tumors: 2015 WHO Classification

William D. Travis, MD, of Memorial Sloan Kettering Cancer Center, gives an update on the WHO classification, which is crucial for optimal personalized treatment of lung cancer pati...

Lung Cancer

Tony Mok, MD, and Fred R. Hirsch, MD, PhD

Tony Mok, MD, and Fred R. Hirsch, MD, PhD: Summary of the IASLC Presidential Symposium

Tony Mok, MD, of The Chinese University of Hong Kong, and Fred R. Hirsch, MD, PhD, of University of Colorado Health Science Center discuss the highlights of the fe...